PDF herunterladen
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2017; 04(02): 144-149
DOI: 10.1016/j.ijep.2017.09.003
Research paper
Thieme Medical and Scientific Publishers Private Ltd.

Amelioration of caffeine-induced seizures by modulators of sigma, N-methyl-d-Aspartate and ryanodine receptors in mice

Mojtaba Keshavarz
a   Department of Pharmacology, Bushehr University of Medical Sciences, Bushehr, Iran
b   Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
,
Seyyed Ahmadreza Hoseini
c   School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
,
Samad Akbarzadeh
d   Department of Biochemistry, Bushehr University of Medical Sciences, Bushehr, Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 06. November 2016

Accepted: 25. September 2017

Publikationsdatum:
06. Mai 2018 (online)

   Lizenzen und Reprints

Abstract

Objectives The aim of this study was to evaluate the antiepileptic effects of opipramol, a sigma receptor agonist, diazepam, ketamine, an N-methyl-d-Aspartate (NMDA) receptor antagonist, and dantrolene, a ryanodine receptor antagonist, against caffeine-induced seizures in mice.

Methods We used caffeine (1000 mg/kg) intraperitoneally for inducing clonic and tonic-clonic seizures in male albino Swiss strain of mice. We used opipramol in three different doses (10, 20 and 50 mg/kg), ketamine (50 mg/kg), dantrolene (40 mg/kg), opipramol (20 mg/kg) plus ketamine (50 mg/kg), opipramol (20 mg/kg) plus dantrolene (40 mg/kg), diazepam (5 mg/kg as a positive control) and the vehicle 30 min before injecting caffeine. We recorded the onset of clonic, tonic-clonic seizures and the time of death of animals after using caffeine.

Results Animals treated with opipramol at a dose of 50 mg/kg or diazepam had a higher onset of clonic seizure compared with the vehicle-treated group. Dantrolene alone or with opipramol (20 mg/kg) increased the latency of clonic seizure compared with the control group. Opipramol (20 and 50 mg/kg), diazepam, ketamine alone or with opipramol, and dantrolene plus opipramol increased the latency of tonic-clonic seizures in mice. All the treatments except opipramol (10 mg/kg) and dantrolene alone increased the latency of death of animals.

Conclusion Opipramol attenuated seizures produced by high doses of caffeine. Moreover, the activation of sigma receptors and inhibition of ryanodine receptors may produce synergistic effects against caffeine-induced seizures. Our study may imply that different mechanisms such as inhibition of gamma-aminobutyric acid-A receptors, activation of NMDA and ryanodine receptors may contribute to the caffeine-induced seizures.

Keywords

Caffeine - Dantrolene - Diazepam - Ketamine - Opipramol
 

  • References

  • 1 James JE. Understanding Caffeine: A Biobehavioral Analysis. 1997. Sage Publications, Inc; Michigan: 240
    Google Scholar
  • 2 Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17 (02) 1992; 139-170
    CrossrefPubMedGoogle Scholar
  • 3 Tilley SL. Methylxanthines in asthma. Fredholm BB. Methylxanthines. 2011. Springer; 439-456
    Google Scholar
  • 4 Henderson-Smart DJ, Steer PA. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev. 3 2001
    PubMedGoogle Scholar
  • 5 Boison D. Methylxanthines, seizures, and excitotoxicity. Fredholm BB. Methylxanthines. 2011. Springer; 251-266
    Google Scholar
  • 6 Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet 352 9125 1998; 383-390
    CrossrefPubMedGoogle Scholar
  • 7 Czuczwar SJ, Gasior M, Janusz W, Szczepanik B, Wlodarczyk D, Kleinrok Z. Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 31 (03) 1990; 318-323
    CrossrefPubMedGoogle Scholar
  • 8 Yoshikawa H. First-line therapy for theophylline-associated seizures. Acta Neurol Scand 115 2007; 57-61
    CrossrefPubMedGoogle Scholar
  • 9 Margineanu DG, Klitgaard H. Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization. Neuropharmacology 47 (06) 2004; 926-934
    CrossrefPubMedGoogle Scholar
  • 10 McPherson PS, Kim YK, Valdivia H. et al. The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7 (01) 1991; 17-25
    CrossrefPubMedGoogle Scholar
  • 11 Nagarkatti N, Deshpande LS, DeLorenzo RJ. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci Lett 436 (03) 2008; 289-293
    CrossrefPubMedGoogle Scholar
  • 12 Ascher P, Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J Physiol 399 1988; 247
    CrossrefPubMedGoogle Scholar
  • 13 Perkel DJ, Petrozzino JJ, Nicoll RA, Connor JA. The role of Ca2+ entry via synaptically activated NMDA receptors in the induction of long-term potentiation. Neuron 11 (05) 1993; 817-823
    CrossrefPubMedGoogle Scholar
  • 14 Tsai SY, Hayashi T, Mori T. Su T-P: Sigma-1 receptor chaperones and diseases. Cent Nerv Syst Agents Med Chem 9 (03) 2009; 184-189
    CrossrefPubMedGoogle Scholar
  • 15 Sha S, Qu WJ, Li L. et al. Sigma-1 receptor knockout impairs neurogenesis in dentate gyrus of adult hippocampus via down-regulation of NMDA receptors. CNS Neurosci Ther 19 (09) 2013; 705-713
    CrossrefPubMedGoogle Scholar
  • 16 Nguyen L, Kaushal N, Robson MJ, Matsumoto RR. Sigma receptors as potential therapeutic targets for neuroprotection. Eur J Pharmacol 743 (00) 2014; 42-47
    CrossrefPubMedGoogle Scholar
  • 17 Kim HC, Jhoo WK, Kim WK. et al. Carbetapentane attenuates kainate-induced seizures via σ-1 receptor modulation. Life Sci 69 (08) 2001; 915-922
    CrossrefPubMedGoogle Scholar
  • 18 Kim HC, Shin CY, Seo DO. et al. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice. Life Sci 72 (16) 2003; 1883-1895
    CrossrefPubMedGoogle Scholar
  • 19 Khanna N, Khosla R, Kohli J. Opioid receptor mediated anticonvulsant effect of pentazocine. Indian J Med Sci 52 (01) 1998; 1-7
    PubMedGoogle Scholar
  • 20 Thurgur C, Church J. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices. Br J Pharmacol 124 (05) 1998; 917-929
    CrossrefPubMedGoogle Scholar
  • 21 Möller HJ, Volz HP, Reimann IW, Stoll KD. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol 21 (01) 2001; 59-65
    CrossrefPubMedGoogle Scholar
  • 22 Müller W, Siebert B, Holoubek G, Gentsch C. Neuropharmacology of the anxiolytic drug opripramol, a sigma site ligand. Pharmacopsychiatry 37 S (03) 2004; 189-197
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 23 Musacchio JM, Klein M, Paturzo JJ. Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H] 3-(-3-hydroxyphenyl)-N-(1-propyl) piperidine. Mol Pharmacol 35 (01) 1989; 1-5
    PubMedGoogle Scholar
  • 24 Rao T, Cler J, Mick S. et al. Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo. Neuropharmacology 29 (12) 1990; 1191-1197
    CrossrefPubMedGoogle Scholar
  • 25 Rao T, Cler J, Mick S. et al. Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology 29 (12) 1990; 1199-1204
    CrossrefPubMedGoogle Scholar
  • 26 Keshavarz M, Yekzaman B. The evaluation of Opipramol, a sigma receptor agonist, effects against pentylenetetrazole-induced seizure in mice. IJMS. 2017 [in press]
    PubMedGoogle Scholar
  • 27 Keshavarz M, Foutohi M, Rasti A. Dantrolen, a selective ryanodine receptor antagonist, protects against pentylenetetrazole-induced seizure in mice. Acta Med Iran 4 (09) 2016; 555-561
    PubMedGoogle Scholar
  • 28 Łukawski K, Czuczwar SJ. Effect of ACE inhibitors and AT1 receptor antagonists on pentylenetetrazole-induced convulsions in mice. Neurol Sci 36 (05) 2015; 779-781
    CrossrefPubMedGoogle Scholar
  • 29 Guo L, Chen Y, Zhao R. et al. Allosteric modulation of sigma-1 receptors elicits anti-seizure activities. Br J Pharmacol 172 (16) 2015; 4052-4065
    CrossrefPubMedGoogle Scholar
  • 30 Zhang H, Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87 (06) 2002; 2867-2879
    CrossrefPubMedGoogle Scholar
  • 31 Monnet FP. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell 97 (12) 2005; 873-883
    CrossrefPubMedGoogle Scholar
  • 32 Vigh J, Lasater EM. Intracellular calcium release resulting from mGluR1 receptor activation modulates GABAA currents in wide-field retinal amacrine cells: a study with caffeine. Eur J Neurosci 17 (11) 2003; 2237-2248
    CrossrefPubMedGoogle Scholar
  • 33 Olsen RW, Avoli M. GABA and epileptogenesis. Epilepsia 38 (04) 1997; 399-407
    CrossrefPubMedGoogle Scholar
  • 34 Inano S. Effects of agonists and antagonists of benzodiazepine, GABA and NMDA receptors, on caffeine-induced seizures in mice. JPN J Psychopharmacol 12 (04) 1992; 199-205
    PubMedGoogle Scholar
  • 35 Hustveit O, Maurset A, Øye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, σ and muscarinic receptors. Pharmacol Toxicol 77 (06) 1995; 355-359
    CrossrefPubMedGoogle Scholar
  • 36 Coates KM, Flood P. Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant σ7 and σ4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes. Br J Pharmacol 134 (04) 2001; 871-879
    CrossrefPubMedGoogle Scholar
  • 37 Marangos P, Martino A, Paul S, Skolnick P. The benzodiazepines and inosine antagonize caffeine-induced seizures. Psychopharmacology (Berl) 72 (03) 1981; 269-273
    CrossrefPubMedGoogle Scholar
  • 38 DeLorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther 105 (03) 2005; 229-266
    CrossrefPubMedGoogle Scholar
  • 39 Pal S, Sun D, Limbrick D, Rafiq A, DeLorenzo RJ. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30 (04) 2001; 285-296
    CrossrefPubMedGoogle Scholar
  • 40 Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 85 (01) 2005; 201-279
    CrossrefPubMedGoogle Scholar
  • 41 Usachev Y, Shmigol A, Pronchuk N, Kostyuk P, Verkhratsky A. Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience 57 (03) 1993; 845-859
    CrossrefPubMedGoogle Scholar
  • 42 Johansson B, Georgiev V, Kuosmanen T, Fredholm BB. Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline-and pentylenetetrazol-induced seizures in mice. Relationship to c-ios expression and receptor binding. Eur J Neurosci 8 (12) 1996; 2447-2458
    CrossrefPubMedGoogle Scholar